Mitigating neuroinflammation in cognitive areas: exploring the impact of HMG-CoA reductase inhibitor
Biochemical Journal · 20.11.2024 · 481 (22) · 1585-1602
DOI: 10.1042/bcj20240217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Journal, online erschienen am 07.11.2024. Verfasst von Carlos Henrique Rocha Catalão und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences and Behavioral Sciences of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto-SP, Brazil. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Rats, Wistar, Sepsis, Simvastatin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: NIA NIH HHS, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Existing literature suggests that infection-specific mechanisms may play a significant role in the onset and progression of dementia, as opposed to the broader phenomenon of systemic inflammation. In addition, 3-hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase inhibitors have been proposed as a potential therapeutic approach for sepsis, given their anti-inflammatory and antioxidant properties. We investigated the neuroprotective effect of an HMG-CoA reductase inhibitor (simvastatin) by analyzing neurodegenerative markers, mitochondrial respiration, and neuronal tracing in the prefrontal cortex (PFC) and thalamic nucleus reuniens (RE) of sepsis survivor animals. Adult Wistar rats were subjected to sepsis by cecal ligation and puncture or left non-manipulated. The animals were treated with simvastatin or vehicle for 4 days before and 10 days after surgery. The treatment preserved the non-associative memory (P < 0.05), recovered expression of Smad-3 in the hippocampus (P < 0.05), and prevented increased expression of calpain-1 (hippocampus: P < 0.0001; PFC: P < 0.05) and GSKβ (hippocampus: P < 0.0001; PFC: P < 0.0001) in the brain structures of the sepsis survivor animals. These animals also showed mitochondrial dysfunction and decreased axon terminals in the RE. Simvastatin seems to restore energy metabolism by improving the electron transfer system (ETS) values in the hippocampus (P < 0.01) and the oxidative phosphorylation/ETS (P/E) ratio in the PFC (P < 0.05), in addition to preventing the reduction of axon terminals in survivor animals. These results suggest a potential neuroprotective effect and the importance of considering HMG-CoA reductase inhibitors as a possible adjuvant therapy in sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences and Behavioral Sciences of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto-SP, Brazil.
- Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, U.S.A.
- Department of Psychology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil.
- Department of Physics and Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil.
- Department of Pharmacology of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto-SP, Brazil.
- Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil.
ORCID-Profile: Diogo Dominguini, Felipe Dal-Pizzol, Tatiana Barichello
Förderung
- NIA NIH HHS
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Catalão, C. H. R., da Costa, L. H. A., Dos Santos, J. R., Alberici, L. C., Falconi-Sobrinho, L. L., Coimbra, N. C., Dominguini, D., Dal-Pizzol, F., Barichello, T., & Rocha, M. J. A. (2024). Mitigating neuroinflammation in cognitive areas: exploring the impact of HMG-CoA reductase inhibitor. Biochemical Journal, 481(22), 1585-1602. https://doi.org/10.1042/bcj20240217
Vancouver
Catalão CHR, da Costa LHA, Dos Santos JR, Alberici LC, Falconi-Sobrinho LL, Coimbra NC, et al. Mitigating neuroinflammation in cognitive areas: exploring the impact of HMG-CoA reductase inhibitor. Biochemical Journal. 2024;481(22):1585-1602. doi:10.1042/bcj20240217
BibTeX
@article{Catalo2024,
author = {Catalão, Carlos Henrique Rocha and da Costa, Luis Henrique Angenendt and Dos Santos, Jonathas Rodrigo and Alberici, Luciane Carla and Falconi-Sobrinho, Luiz Luciano and Coimbra, Norberto Cysne and Dominguini, Diogo and Dal-Pizzol, Felipe and Barichello, Tatiana and Rocha, Maria José Alves},
title = {Mitigating neuroinflammation in cognitive areas: exploring the impact of HMG-CoA reductase inhibitor},
journal = {Biochemical Journal},
year = {2024},
volume = {481},
number = {22},
pages = {1585--1602},
doi = {10.1042/bcj20240217}
}
EUVIMED